On Thursday, Shares of Citigroup Inc. (NYSE:C), gained 0.08% to $51.79.
Citigroup signed an agreement with Erste Bank Hungary Zrt. and its subsidiary Erste Befektetési Zrt. (Erste Investment) to sell its consumer banking business in Hungary. The sale includes Citi’s retail banking, consumer loans, cards businesses, and the transfer of consumer banking employees. This transaction is subject to regulatory approvals, which are expected by the end of 2015. Transfer of customer accounts is expected to be completed in Q4 2016. The financial terms of the transaction are not material to Citi.
Citi will remain in Hungary and intends to focus on expanding the services it offers to Hungarian corporations, financial institutions, and public sector clients. Citi will continue to service its multi-national clients with operations in Hungary. Citi also remains committed to operating and expanding its Citi Service Center located in Budapest, currently serving over 50 countries worldwide.
Citigroup Inc., a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions worldwide. The company operates through two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG).
Shares of Boston Scientific Corporation (NYSE:BSX), remained flat to $16.53, during its last trading session.
Boston Scientific Corporation is planned to take part in the 2015 Morgan Stanley Global Healthcare Conference on September 17, in New York City.
Mike Mahoney, chief executive officer, and Dan Brennan, executive vice president and chief financial officer, will take part in a 30-minute question and answer session regarding the company with the host analyst starting at about 8:35 a.m. ET.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg.
Finally, Chemical & Mining Co. of Chile Inc. (NYSE:SQM), ended its last trade with 4.76% gain, and closed at $16.30.
Chemical & Mining Co. of Chile stated earnings for the six months ended June 30, 2015 of US$154.9 million (US$0.59 per ADR), an improvement from US$152.1 million (US$0.58 per ADR) for the six months ended June 30, 2014. Gross Margin reached US$295.2 million (33.9% of revenues) for the six months ended June 30, 2015, slightly lower than US$300.2 million (28.4% of revenues) recorded for the six months ended June 30, 2014. Revenues totaled US$871.8 million for the six months ended June 30, 2015, representing a decrease of 17.5% contrast to US$1,056.4 million stated for the six months ended June 30, 2014.
The Company also declared earnings for the second quarter of 2015, reporting net income of US$83.2 million (US$0.32 per ADR) contrast to US$71.1 million (US$0.27 per ADR) for the second quarter of 2014. Gross Margin for the second quarter of 2015 reached US$164.6 million, higher than the US$145.3 million recorded for the second quarter of 2014. Revenues totaled US$484.2 million, a decrease of about 7.3% contrast to the second quarter of 2014, when revenues amounted to US$522.3 million.
Chemical and Mining Company of Chile Inc. produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, industrial chemicals, potassium, and other products and services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
